Pfizer-BioNTech bivalent booster shows higher immune response, but new COVID cases climb back above 40,000 a day
First the good news: Pfizer Inc. and Germany-based partner BioNTech SE said updated trial data…
Read MoreFirst the good news: Pfizer Inc. and Germany-based partner BioNTech SE said updated trial data…
Read MoreA new, highly infectious subvariant of omicron is raising concerns among scientists and health experts…
Read More